Clinical Trials in Netherlands — Country Dashboard | 2,311 EU Studies

Filter these 2,311 trials by condition, phase, sponsor and more.

Open in Search →

2,311 Registered trials

932 Recruiting

1,219 Completed trials

589 Sponsors active

352 Research sites

Phase III

Phase II

Phase IV

Phase III: 874 Phase II/III: 100 Phase II: 515 Phase I/II: 125 Phase III/IV: 53 Phase IV: 224 Phase I: 136 Phase I (Other): 170 Phase I (FiH): 101 Other: 13 Other: 1

Oversight events in trials active here:

116 serious breaches 497 temporary halts 35 urgent safety measures 70 unexpected events 88 corrective measures across 308 trials

View oversight register →

Top conditions

Non-small cell lung cancer 79 Non-small cell lung cancer metastatic 22 Crohn's disease 19 Prostate cancer metastatic 18 Amyotrophic lateral sclerosis 15 Colitis ulcerative 15 Diffuse large B-cell lymphoma 14 Colorectal cancer 14 Systemic lupus erythematosus 13 Pulmonary arterial hypertension 12 Endometrial cancer 11 Chronic obstructive pulmonary disease 11

Top sponsors

Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC) 85 Amsterdam UMC Stichting 84 Novartis Pharma AG 84 AstraZeneca AB 74 Merck Sharp & Dohme LLC 72 Universitair Medisch Centrum Groningen 62 Janssen - Cilag International 58 F. Hoffmann-La Roche AG 53 Amsterdam UMC 47 Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting 47 AbbVie Deutschland GmbH & Co. KG 45 Boehringer Ingelheim International GmbH 43

Cities with most trials

All 120 cities →

All trials — page 43

2,311 total

A Safety Study of PF-08046040/SEA-CD70 in Patients with Myeloid Malignancies Recruiting

2023-506945-42-00 Phase I Acute myeloid leukaemia Seagen Inc.
Selatogrel Outcome Study in Suspected Acute Myocardial Infarction Recruiting

2023-505438-85-00 Phase III Acute myocardial infarction (AMI) Viatris Innovation GmbH
Safety, efficacy and pharmacokinetics of sparsentan in pediatric subjects with selected kidney diseases. Recruiting

2023-505497-14-00 Phase II Proteinuric glomerular diseases including: •Focal segmental… Travere Therapeutics Inc.
SIOP-HRMB: An international prospective trial on clinically high-risk medulloblastoma (HR-MB) in patients older than 3 years. Recruiting

2024-510578-25-00 Phase III Histologically proven high-risk medulloblastoma, with any of… The University Of Birmingham
HARBOR: Study of BLU-263 for Indolent Systemic Mastocytosis Recruiting

2024-516728-32-00 Phase II/III Indolent Systemic Mastocytosis and SSM Blueprint Medicines Corp.
Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Efgartigimod Administered Intravenously in Children With Generalized Myasth… Recruiting

2024-513854-31-00 Phase II/III Generalized Myasthenia Gravis Argenx
Low INR to Minimize bleeding with mechanical valves Trial (LIMIT) Recruiting

2023-508532-56-00 Phase III Treatment with a Vitamin K Antagonist due to having a mechan… Hamilton Health Sciences Corporation
A Phase 2 Study to Test Effects of Using DAY101 in Children with Brain Cancer Recruiting

2024-510691-20-00 Phase II RAF-Altered, Recurrent or Progressive Low-Grade Glioma and A… Day One Biopharmaceuticals Inc.
Beamion LUNG-1: A study to test different doses of zongertinib in people with different types of advanced cancer (solid tumours with changes… Recruiting

2024-511246-39-00 Phase I Solid tumours with HER2 aberrations Boehringer Ingelheim Espana S.A.; Boehringer Ingelheim International GmbH
Partial oral antibiotic treatment for bacterial brain abscess: An open-label randomised non-inferiority trial (ORAL) Recruiting

2023-505483-11-00 Phase IV Brain abscess Aalborg University Hospital
Apremilast Study in Children with Active Juvenile Psoriatic Arthritis Recruiting

2023-503435-17-00 Phase III Juvenile psoriatic arthritis Amgen Inc.
FIGO 2018 stage IB2 (>2 cm - ≤4 cm ) Cervical Cancer Treated with Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery (CoNteSSa)… Recruiting

2023-507230-24-00 Phase II Cervical cancer Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting; Uni…
PAmidronate for Pain in Sternocostoclavicular hyperostosis: the PAPS-study, a double-blind randomized placebo-controlled trial Recruiting

2023-510309-16-00 Phase III Inflammation of sternal region Academisch Ziekenhuis Leiden
A First-in-Human Study to Evaluate the Safety and Anti-cancer Activity of the product FS222, which is an Antibody medication, in Subjects wi… Recruiting

2024-514010-12-00 Phase I Advanced Malignancies Invox Pharma Limited
GROINSS-V III Recruiting

2023-508722-99-00 Phase II Vulvar cancer Universitair Medisch Centrum Groningen
Study of REGN4018 (Ubamatamab) Administered Alone or in Combination with Cemiplimab in Adult Patients with Recurrent Ovarian Cancer or Other… Recruiting

2024-510783-23-00 Phase I (FiH) Fallopian Tube Cancer Regeneron Pharmaceuticals Inc.
Multicentre, open-label, randomized, controlled, parallel arms clinical trial of induction chemotherapy followed by chemoradiotherapy versus… Recruiting

2024-512526-28-00 Phase III Locally recurrent rectal cancer Catharina Ziekenhuis Stichting
FaR-RMS: An overarching study for children and adults with Frontline and Relapsed RhabdoMyoSarcoma Recruiting

2024-510579-40-00 Phase I/II Rhabdoyosarcoma The University Of Birmingham
A study of Trastuzumab Deruxtecan to assess its safety, tolerability, immune response, and inhibition of tumor activity when given alone or … Recruiting

2023-504888-16-00 Phase I/II Patients with Human Epidermal Growth Factor Receptor 2 (HER2… AstraZeneca AB
A clinical study of the safety and effectiveness of an investigational cell therapy given with and without an investigational RNA-based vacc… Recruiting

2024-514962-38-00 Phase I Solid Tumors BioNTech Cell & Gene Therapies GmbH
Goal directed fluid removal in critically ill patients with fluid overload Recruiting

2024-512186-14-00 Phase IV Fluid overload/fluid accumulation Region Hovedstaden
A study to assess the long-term safety and efficacy of a subcutaneous formulation of efgartigimod in adults with chronic inflammatory demyel… Recruiting

2023-507885-21-00 Phase II Chronic Inflammatory Demyelinating Polyneuropathy Argenx
Treatment of chronic lymphocytic leukaemia with venetoclax and acalabrutinib in case of return of the disease after previous treatment with … Recruiting

2023-505449-18-00 Phase II Patients with relapsed CLL Haemato Oncology Foundation For Adults Netherlands
An international trial for children with atypical teratoid/rhabdoid tumours (ATRT) Recruiting

2022-501456-28-00 Phase III atypical teratoid/rhabdoid tumours (ATRT) GPOH gGmbH

Showing 1,009–1,032 of 2,311 trials

← All countries